Kinase Inhibitors
Selective inhibitors for over 500 kinases including PI3K, mTOR, EGFR, VEGFR, CDK, JAK, and MAPK pathway —” with high purity (>99%) and cellular potency data.
Small molecule inhibitors, chemical probes, and compound libraries for drug discovery and mechanistic research.
Selective inhibitors for over 500 kinases including PI3K, mTOR, EGFR, VEGFR, CDK, JAK, and MAPK pathway —” with high purity (>99%) and cellular potency data.
HDAC inhibitors, DNMT inhibitors, BET bromodomain inhibitors, histone methyltransferase inhibitors, and demethylase probes for epigenetics research.
Caspase inhibitors, Bcl-2 family inhibitors, autophagy modulators (Rapamycin, Chloroquine, Bafilomycin), and pathway-specific research tools.
Bioactive natural compounds including alkaloids, flavonoids, terpenoids, and polyketides —” sourced from plants, fungi, and marine organisms for drug lead discovery.
Curated compound libraries for HTS —” including FDA-approved drug collections, kinase-focused libraries, and natural product diversity sets in DMSO or dry powder format.
Proteasome inhibitors (MG132, Bortezomib), ubiquitin pathway modulators, and PROTAC reference molecules for targeted protein degradation research.
Kinase inhibitors, epigenetic probes, and more —” competitive pricing with expert guidance from Bio Solutions India.